Related Experiment Video
Updated: Jan 23, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
A study on regulatory mechanism of miR-223 in ulcerative colitis through PI3K/Akt-mTOR signaling pathway
1Department of Gastroenterology, First Affiliated Hospital of Jiamusi University, Jiamusi, China. dncc_321@163.com.
Objective:
The aim of this study was to explore the regulatory mechanism of micro ribonucleic acid (miR)-223 in ulcerative colitis (UC) through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)-mammalian target of rapamycin (mTOR) signaling pathway.
Materials And Methods:
A total of 36 Sprague-Dawley (SD) rats were randomly divided into three groups, including normal group (n=12), model group (n=12) and inhibitor group (n=12). Rats in the normal group received no treatment. Rats in the model group were used to establish a UC model. Meanwhile, rats in the inhibitor group underwent intraperitoneal injection of inhibitor and establishment of the UC model. Subsequently, specimens were obtained for detection. Immunohistochemistry was applied to measure the expression of mTOR. Western blotting was adopted to determine the relative protein expressions of P85, P110 and phosphorylated Akt (p-Akt). Quantitative polymerase chain reaction (qPCR) was used to detect the mRNA expression of miR-223. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) was utilized to determine cell apoptosis. Furthermore, an enzyme-linked immunosorbent assay (ELISA) was conducted to measure the content of interleukin-1 beta (IL-1β) and IL-6.
Results:
Immunohistochemistry showed that the positive expression of mTOR increased remarkably in the model group and inhibitor group when compared with that of the normal group (p<0.05). However, it decreased notably in the inhibitor group when compared with the model group (p<0.05). Western blotting indicated that the protein expressions of P85, P110 and p-Akt in model group and inhibitor group were significantly higher than the ones of the normal group (p<0.05). However, the inhibitor group showed markedly lower relative protein expressions of P85, P110 and p-Akt than the ones of the model group (p<0.05). Compared with the normal group, the expression level of miR-223 was significantly elevated in model group and inhibitor group (p<0.05). However, there was no significant difference in the mRNA expression of miR-233 between the model group and the inhibitor group (p>0.05). The apoptosis rate of the cells increased prominently in the model group and in the inhibitor group when compared with the normal group (p<0.05). However, it was remarkably reduced in the inhibitor group than the model group (p<0.05). In comparison with the normal group, the content of IL-1β and IL-6 was significantly up-regulated in the model group and in the inhibitor group (p<0.05). However, it declined notably in the inhibitor group compared with the model group (p<0.05).
Conclusions:
MiR-223 can trigger cell apoptosis and inflammation in UC by up-regulating the PI3K/Akt-mTOR signaling pathway.
Insights
MicroRNA-223 (miR-223) exacerbates ulcerative colitis (UC) by activating the PI3K/Akt-mTOR pathway, leading to increased inflammation and cell apoptosis. Inhibiting miR-223 shows therapeutic potential in UC models.
Area of Science:
- Molecular Biology
- Gastroenterology
- Immunology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease with complex regulatory mechanisms.
- MicroRNAs (miRNAs) play crucial roles in inflammatory diseases, but their specific roles in UC require further elucidation.
- The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)-mammalian target of rapamycin (mTOR) signaling pathway is implicated in cell proliferation, survival, and inflammation.
Purpose of the Study:
- To investigate the regulatory role of microRNA-223 (miR-223) in ulcerative colitis (UC).
- To explore the involvement of the PI3K/Akt-mTOR signaling pathway in miR-223-mediated UC pathogenesis.
- To assess the therapeutic potential of targeting miR-223 in a rat model of UC.
Main Methods:
- Establishment of a UC rat model.
- Treatment with a miR-223 inhibitor in a subset of UC rats.
- Assessment of mTOR expression via immunohistochemistry.
- Quantification of PI3K/Akt pathway proteins (P85, P110, p-Akt) using Western blotting.
- Measurement of miR-223 mRNA levels via quantitative polymerase chain reaction (qPCR).
- Evaluation of cell apoptosis using TUNEL assay.
- Determination of inflammatory cytokine levels (IL-1β, IL-6) via ELISA.
Main Results:
- UC induction led to increased mTOR, P85, P110, p-Akt, miR-223, IL-1β, IL-6, and cell apoptosis.
- Inhibition of miR-223 significantly reduced mTOR, P85, P110, p-Akt, IL-1β, IL-6, and cell apoptosis.
- While miR-223 expression was elevated in UC, its levels did not significantly change between UC and miR-223 inhibitor groups, suggesting miR-223 acts upstream or parallel to the inhibitor's direct effect on the pathway.
Conclusions:
- MiR-223 promotes cell apoptosis and inflammation in ulcerative colitis.
- These effects are mediated through the up-regulation of the PI3K/Akt-mTOR signaling pathway.
- Targeting miR-223 demonstrates therapeutic promise for managing UC.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

